131 related articles for article (PubMed ID: 22462533)
1. Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir.
Bech A; Van Bentum P; Nabbe K; Gisolf J; Richter C; De Boer H
HIV Med; 2012 Oct; 13(9):558-63. PubMed ID: 22462533
[TBL] [Abstract][Full Text] [Related]
2. Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
Badiou S; De Boever CM; Terrier N; Baillat V; Cristol JP; Reynes J
J Infect; 2006 May; 52(5):335-8. PubMed ID: 16176835
[TBL] [Abstract][Full Text] [Related]
3. Treatment of calcium and vitamin D deficiency in HIV-positive men on tenofovir-containing antiretroviral therapy.
Bech A; Van Bentum P; Telting D; Gisolf J; Richter C; De Boer H
HIV Clin Trials; 2012; 13(6):350-6. PubMed ID: 23195673
[TBL] [Abstract][Full Text] [Related]
4. Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology.
Schmid H; Tokarska-Schlattner M; Füeßl B; Röder M; Kay L; Attia S; Lederer SR; Goebel FD; Schlattner U; Bogner JR
Antivir Ther; 2013; 18(2):193-204. PubMed ID: 22894916
[TBL] [Abstract][Full Text] [Related]
5. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
Havens PL; Kiser JJ; Stephensen CB; Hazra R; Flynn PM; Wilson CM; Rutledge B; Bethel J; Pan CG; Woodhouse LR; Van Loan MD; Liu N; Lujan-Zilbermann J; Baker A; Kapogiannis BG; Gordon CM; Mulligan K;
Antimicrob Agents Chemother; 2013 Nov; 57(11):5619-28. PubMed ID: 24002093
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.
Buchacz K; Brooks JT; Tong T; Moorman AC; Baker RK; Holmberg SD; Greenberg A;
HIV Med; 2006 Oct; 7(7):451-6. PubMed ID: 16925731
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.
Saeedi R; Jiang SY; Holmes DT; Kendler DL
Calcif Tissue Int; 2014 Jun; 94(6):665-8. PubMed ID: 24706031
[TBL] [Abstract][Full Text] [Related]
8. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
[TBL] [Abstract][Full Text] [Related]
10. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
[TBL] [Abstract][Full Text] [Related]
12. Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
Wainwright E; Sherrard J; Duncan S; Shine B; Dorrell L
Int J STD AIDS; 2013 Jul; 24(7):579-81. PubMed ID: 23970775
[TBL] [Abstract][Full Text] [Related]
13. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.
Vrouenraets SM; Fux CA; Wit FW; Garcia EF; Furrer H; Brinkman K; Hoek FJ; Abeling NG; Krediet RT; Reiss P;
AIDS; 2011 Nov; 25(17):2149-55. PubMed ID: 21857491
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.
Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E
West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479
[TBL] [Abstract][Full Text] [Related]
15. Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.
Antoniou T; Raboud J; Chirhin S; Yoong D; Govan V; Gough K; Rachlis A; Loutfy M
HIV Med; 2005 Jul; 6(4):284-90. PubMed ID: 16011534
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
Westerberg PA; Ljunggren O; Larsson TE; Wadström J; Linde T
Nephrol Dial Transplant; 2010 Dec; 25(12):4068-71. PubMed ID: 20525976
[TBL] [Abstract][Full Text] [Related]
19. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
Han SY; Hwang EA; Park SB; Kim HC; Kim HT
Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
[TBL] [Abstract][Full Text] [Related]
20. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.
Izzedine H; Hulot JS; Vittecoq D; Gallant JE; Staszewski S; Launay-Vacher V; Cheng A; Deray G;
Nephrol Dial Transplant; 2005 Apr; 20(4):743-6. PubMed ID: 15741212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
